RNAConnect, a leader in next-generation molecular biology tools, today announced the commercial launch of the UltraMarathonRT ...

In fact, Illumina’s dominance in the sequencing market largely stems from the 2007 acquisition of Solexa, which gave Illumina the foundation of its sequencing-by-synthesis chemistry in its ...

The MiSeq System can go from DNA to data in just over 8 hours. A compact, all-in-one platform incorporates cluster generation, paired-end fluidics, sequencing by synthesis chemistry, and data ...

Illumina, Inc. (NASDAQ:ILMN), standing twelfth among best biotech stocks to buy according to billionaires, is a leading biotech company specializing in genetic sequencing and analysis.